<oai_dc:dc xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:oai_dc="http://www.openarchives.org/OAI/2.0/oai_dc/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/oai_dc/ http://www.openarchives.org/OAI/2.0/oai_dc.xsd">
  <dc:creator>Nordmann, Patrice</dc:creator>
  <dc:creator>Kerbol, Auriane</dc:creator>
  <dc:creator>Bouvier, Maxime</dc:creator>
  <dc:creator>Sadek, Mustafa</dc:creator>
  <dc:creator>Poirel, Laurent</dc:creator>
  <dc:creator>Hallal Ferreira Raro, Otavio</dc:creator>
  <dc:date>2023</dc:date>
  <dc:description xmlns:ns0="xml" ns0:lang="en">Background: The treatment options for infections caused by carbapenem-resistant Enterobacterales (CRE) are extremely scarce nowadays and the development of new antibiotics does not follow the exponential increase in the dissemination of carbapenem resistance determinants worldwide. Meropenem/vaborbactam was recently approved for clinical use and it has been indicated for treating several infections. Although relatively rare, meropenem/vaborbactam resistance has already been reported in Enterobacterales and its early detection could be a valuable tool for faster clinical decision-making.

Objectives: To develop a rapid test, namely the Rapid MEV NP, for the identification of meropenem/vaborbactam resistance in Enterobacterales.

Methods: The Rapid MEV NP test is based on detection of glucose metabolization occurring upon bacterial growth in the presence of meropenem/vaborbactam at a concentration of 16/8 mg/L. Bacterial growth is detectable by a colour change of phenol red (from red to yellow) subsequent of the acidification of the medium upon bacterial growth. A total of 75 Enterobacterales isolates were randomly selected for evaluating the performance of the Rapid MEV NP test.

Results: The test showed 97.2% sensitivity and 93.8% specificity when compared with the reference method. The results are obtained after 3 h of incubation at 35°C ± 2°C, which is a gain of time of at least 15 h (one day in practice) compared with currently used antimicrobial susceptibility testing including broth microdilution methods.

Conclusions: The Rapid MEV NP test, easy to perform and to interpret, showed remarkable performance while providing fast results, and is therefore suitable for implementation in routine clinical microbiology laboratories.</dc:description>
  <dc:format>application/pdf</dc:format>
  <dc:identifier>https://sonar.ch/global/documents/328449</dc:identifier>
  <dc:identifier>https://sonar.ch/documents/328449/files/nordmann2023_mev.pdf</dc:identifier>
  <dc:language>eng</dc:language>
  <dc:relation>info:eu-repo/semantics/altIdentifier/doi/10.1093/jac/dkad224</dc:relation>
  <dc:relation>info:eu-repo/semantics/altIdentifier/issn/0305-7453</dc:relation>
  <dc:relation>info:eu-repo/semantics/altIdentifier/issn/1460-2091</dc:relation>
  <dc:rights>info:eu-repo/semantics/openAccess</dc:rights>
  <dc:rights>CC BY</dc:rights>
  <dc:source>Journal of Antimicrobial Chemotherapy. - Oxford, UK : Oxford University Press. - 2023, vol. 78, no. 10, p. 1-7</dc:source>
  <dc:subject xmlns:ns1="xml" ns1:lang="en">color</dc:subject>
  <dc:subject xmlns:ns2="xml" ns2:lang="en">infections</dc:subject>
  <dc:subject xmlns:ns3="xml" ns3:lang="en">meropenem</dc:subject>
  <dc:subject xmlns:ns4="xml" ns4:lang="en">antimicrobial susceptibility test</dc:subject>
  <dc:subject xmlns:ns5="xml" ns5:lang="en">vaborbactam</dc:subject>
  <dc:subject>info:eu-repo/classification/udc/61</dc:subject>
  <dc:title xmlns:ns6="xml" ns6:lang="en">Rapid meropenem/vaborbactam NP test for detecting susceptibility/resistance in Enterobacterales</dc:title>
  <dc:type>http://purl.org/coar/resource_type/c_6501</dc:type>
</oai_dc:dc>
